OGN

Organon & Co.

Healthcare›Drug Manufacturers - General|New York Stock Exchange|US

Price

$6.36

Market Cap

$1.66B

Beta

0.64

P/E

8.6

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-2.92%

EPS Growth (YoY)-78.68%

Revenue CAGR 3Y+0.23%

P/E Ratio8.6

PEG Ratio—

FCF Yield+24.40%

Debt / Equity11.70

Interest Coverage2.5x

No credit card required

Already have an account? Sign in to view the full analysis for OGN.